Johnson & Johnson told to pay compensation

FILE PHOTO: Security guards stand outside the office of Johnson & Johnson in Mumbai, India   | Photo Credit: Reuters

The Central Drugs Standard Control Organisation (CDSCO) has issued directions to Johnson & Johnson Private Limited (J&J) for the payment of ₹74.5 lakh as compensation to the first patient in the case of faulty ASR (Articular Surface Replacement) hip implants manufactured and imported by M/s DePuy International Limited (now Johnson & Johnson Pvt. Ltd.).

“Based on the recommendations of the Central Expert Committee and the State Level Committee, we issued the direction on March 8 to pay ₹74,57,180, within a period of 30 days from the date of receipt of the order, as compensation to the patient, and submit an acknowledgement from the patient on the compensation paid in the said period,” said the release issued by CDSCO here on Sunday.

Meanwhile, the CEC, after detailed deliberations claims to have prepared a formula for determining compensation for the ASR hip implant victim patients.

“The recommendation as received from the SLC was perused and examined by the CEC in it meeting. It maintained that the patient implanted with faulty ASR Hip Implant on both hips and subsequent revision of left hip, is entitled for the financial compensation as per the formula,” the release said.

Our code of editorial values

This article is closed for comments.
Please Email the Editor

Printable version | Sep 19, 2021 4:11:29 AM |

Next Story